MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$426,175
Net Income
-$26,415
Net Profit Margin
-6.20%
Unit: Dollar
Revenue Breakdown
    • Customers And Direct Sales
    • Medical And Academic
    • Reseller
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net sales
426,175
385,641
507,755
445,970
Cost of sales
77,887
66,867
81,358
93,514
Gross profit
348,288
318,774
426,397
352,456
Distributors incentives
1,658
2,343
2,316
2,987
Selling, general and administrative (including equity compensation granted to officers, directors and contractors of 30,353 in the period ended march 31, 2026 and 75,633 in the period ended march 31, 2025)
396,394
527,089
432,540
456,728
Amortization expense
-
0*
0
-
Impairment expense
-
725,000*
-
-
Total operating expenses
398,052
1,254,432
434,856
459,715
Loss from operations
-49,764
-935,658
-8,459
-107,259
Write-off of accrued liabilities
81,334
-
-
-
Other income
19,101
-
-
-
Interest expense and financing costs (including related party interest of 38,088 in the three months ended in march 31, 2026 and 35,455 in march 31, 2025
77,086
82,147
72,106
-
Interest expense and financing costs (including related party interest of 35,455 in the six months ended in june 30, 2025 and 31,063 in june 30, 2024
-
-
-
71,086
Other income and expense (net)
23,349
-
-
-
Net loss
-26,415
-1,017,805
-80,565
-178,345
Foreign currency translation adjustment
0
0
7,222
-7,197
Other comprehensive loss
-26,415
-1,017,805
-73,343
-185,542
Basic EPS
0
-0.001
0
0
Diluted EPS
0
-0.001
0
0
Basic Average Shares
969,173,181
961,767,430
960,873,144
959,205,422
Diluted Average Shares
969,173,181
961,767,430
960,873,144
959,205,422
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Other comprehensiveloss-$26,415 (90.18%↑ Y/Y)Write-off of accruedliabilities$81,334 Customers And Direct Sales$233,983 Medical And Academic$121,560 Reseller$70,632 Other income$19,101 Net loss-$26,415 (90.10%↑ Y/Y)Other income andexpense (net)$23,349 Net sales$426,175 (-17.27%↓ Y/Y)Interest expense andfinancing costs...$77,086 Loss from operations-$49,764 (74.16%↑ Y/Y)Gross profit$348,288 (-14.22%↓ Y/Y)Cost of sales$77,887 (-28.62%↓ Y/Y)Total operatingexpenses$398,052 (-33.51%↓ Y/Y)Selling, general andadministrative (including...$396,394 (-32.86%↓ Y/Y)Distributors incentives$1,658 (-79.97%↓ Y/Y)

BIOREGENX, INC. (BRGX)

BIOREGENX, INC. (BRGX)